Division Chief, Hematology/Oncology, Boston Children’s HospitalAssociate Chair, Pediatric Oncology, Dana-Farber Cancer Institute
Dr. David A. Williams is a graduate of Indiana State University and Indiana University School of Medicine. After training in Pediatrics at Cincinnati Children's Hospital Medical Center, Dr. Williams completed fellowship training in Pediatric Hematology/Oncology at Dana-Farber/Boston Children's. He completed his research training there and at the Whitehead Institute at the Massachusetts Institute of Technology. He then became a faculty member at Harvard Medical School and of the Howard Hughes Medical Institute (HHMI).
Department Chair, Pediatric Oncology, Dana-Farber Cancer InstituteAssociate Chief, Division of Hematology/Oncology, Boston Children’s Hospital
Dr. Stuart Orkin received his MD in 1972 from Harvard Medical School, followed by postdoctoral research at the National Institutes of Health and clinical training in pediatrics and hematology-oncology at Dana-Farber/Boston Children's, where he joined the faculty in 1978. Dr. Orkin is a Howard Hughes Medical Institute Investigator. Over the past decade, his laboratory has defined critical nuclear regulators of hematopoiesis.
Chief Medical Officer, Dana-Farber/Boston Children's Cancer and Blood Disorders CenterClinical Director, Pediatric Oncology, Dana-Farber Cancer InstituteFounding Director, David B. Perini, Jr. Quality of Life Clinic, Dana-Farber Cancer Institute
Dr. Lisa Diller leads the joint clinical Pediatric Oncology Program at Dana-Farber/Boston Children's. She is also the Director of the Perini Family Survivors Center and the David B. Perini, Jr. Quality of Life Clinic for Cancer Survivors at Dana-Farber. She is a Professor of Pediatrics at Harvard Medical School. Dr. Diller received a bachelors degree from Harvard University, and earned her medical degree from the University of California at San Diego.
Rated the top pediatriccancer center by U.S. News & World Report